Others have also shown that PDE4 inhibitors can reduce basal inflammatory levels of IL-8 in HBECs obtained from patients with the severe inflammatory respiratory disorder: bronchiolitis obliterans syndrome [24]. Here, CXCL8 is linked to bronchiolitis obliterans syndrome.